Healthcare entity
University College London is most often covered alongside Aerogel, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 146-day span. Each story carries 2.5 original sources on average, compared with 3.8 for the broader beat in this window.
Last mentioned: Aug 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
University College London is most often covered alongside Aerogel, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 146-day span. Each story carries 2.5 original sources on average, compared with 3.8 for the broader beat in this window. At 6.5, the average consequence score sits above the same-window beat average of 6.1. market-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. University College London appears in 2 tracked Healthcare stories published from March 20, 2026 through August 12, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 568 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University College London. Shared-story counts are live from our verified record — not editorial picks.
Commercial Scalability Assessment
Evaluation of bio-foundry partnerships to standardize the production of engineered scaffolds.
Regulatory Submission
Expected filing for Advanced Therapy Medicinal Product (ATMP) designation with the MHRA.
Expanded Clinical Trials
Anticipated start of Phase II trials involving a larger cohort of pediatric patients with long-gap OA.
Breakthrough Announcement
First successful lab-grown oesophagus for pediatric use is unveiled to the public.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Source: plymouthherald.co.uk · gazettelive.co.uk
Researchers have successfully engineered the first lab-grown oesophagus, providing a transformative solution for children born with Oesophageal Atresia. This tissue-engineered breakthrough uses a patient's own cells to create a functional organ, potentially eliminating the need for high-risk invasive surgeries.
Source: oxfordmail.co.uk · london-now.co.uk
University College London is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
